- | Separation date | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Mode of separation | Number
[1]
| 1 | Discharge/transfer to (an)other acute hospital | 2 | Discharge/transfer to a residential aged care service, unless this is the usual place of residence | 3 | Discharge/transfer to (an)other psychiatric hospital | 4 | Discharge/transfer to other health care accommodation (includes mothercraft hospitals) | 5 | Statistical discharge - type change | 6 | Left against medical advice/discharge at own risk | 7 | Statistical discharge from leave | 8 | Died | 9 | Other (includes discharge to usual residence, own accommodation/welfare institution (includes prisons, hostels and group homes providing primarily welfare services)) |
| |
- | Date patient presents | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Time patient presents | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | |
- | Date of referral to rehabilitation | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: Required to derive those referred to a rehabilitation service from those eligible to attend and who actually attend. This metadata item can be used to determine the time lag between referral and commencement of rehabilitation. |
- | Creatine kinase MB isoenzyme—upper limit of normal range (index code) | Number
[4]
| 9999 | Not stated/inadequately described |
| |
- | Creatine kinase MB isoenzyme—upper limit of normal range (percentage) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| |
- | Creatine kinase MB isoenzyme—upper limit of normal range (international units) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| |
- | Creatine kinase MB isoenzyme—upper limit of normal range (kCat per litre) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| |
- | Creatine kinase MB isoenzyme—upper limit of normal range (micrograms per litre) | Number
[4]
| 9999 | Not stated/inadequately described | 8888 | Not measured |
| |
- | Creatine kinase MB isoenzyme—upper limit of normal range (nanograms per decilitre) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| |
- | Troponin assay—upper limit of normal range (micrograms per litre) | Number
[4]
| 9999 | Not stated/inadequately described |
| |
- | Triage category | Number
[1]
| 1 | Resuscitation: immediate (within seconds) | 2 | Emergency: within 10 minutes | 3 | Urgent: within 30 minutes | 4 | Semi-urgent: within 60 minutes | 5 | Non-urgent: within 120 minutes |
| |
- | Type of visit to emergency department | Number
[1]
| 1 | Emergency presentation: attendance for an actual or suspected condition which is sufficiently serious to require acute unscheduled care. | 2 | Return visit, planned: presentation is planned and is a result of a previous emergency department presentation or return visit. | 3 | Pre-arranged admission: a patient who presents at the emergency department for either clerical, nursing or medical processes to be undertaken, and admission has been pre-arranged by the referring medical officer and a bed allocated. | 4 | Patient in transit: the emergency department is responsible for care and treatment of a patient awaiting transport to another facility. | 5 | Dead on arrival: a patient who is dead on arrival at the emergency department. |
| |
- | Concurrent clinical condition (on presentation) | Number
[2]
| 11 | Angina for more than last two weeks | 12 | Angina only in the last two weeks | 21 | Chronic lung disease | 31 | Heart failure | 41 | Hypertension | 51 | Ischaemic: non-haemorrhagic cerebral infarction | 52 | Haemorrhagic: intracerebral haemorrhage | 61 | Peripheral artery disease | 62 | Aortic aneurysm | 63 | Renal artery stenosis | 71 | Sleep apnoea | 99 | not stated/inadequately described |
| |
- | Acute coronary syndrome procedure type | String
[2]
| 01 | Coronary artery bypass graft (CABG) | 02 | Coronary stent (bare metal) | 03 | Coronary stent (drug eluding) | 04 | Angioplasty | 05 | Reperfusion fibrinolytic therapy | 06 | Reperfusion primary percutaneous coronary intervention (PCI) | 07 | Rescue angioplasty/stenting | 08 | Vascular reconstruction, bypass surgery, or percutaneous intervention to the extremities or for aortic aneurysm | 09 | Amputation for arterial vascular insufficiency | 10 | Diagnostic cardiac catheterisation/angiography | 11 | Blood transfusion | 12 | Insertion of pacemaker | 13 | Implantable cardiac defibrillator | 14 | Intra-aortic balloon pump (IABP) | 15 | Non-invasive ventilation (CPAP) | 16 | Invasive ventilation | 17 | Defibrillation | 88 | Other | 99 | Not stated/inadequately described |
| |
- | Acute coronary syndrome stratum | Number
[1]
| 1 | with ST elevation (myocardial infarction) | 2 | with non-ST elevation ACS with high-risk features | 3 | with non-ST elevation ACS with intermediate-risk features | 4 | with non-ST elevation ACS with low-risk features | 9 | Not reported |
| |
- | Angiotensin converting enzyme (ACE) inhibitors therapy status | Number
[2]
| 10 | Given | 21 | Not given - patient refusal | 22 | Not given - allergy or intolerance (e.g. cough) to ACE inhibitors | 23 | Not given - moderate to severe aortic stenosis | 24 | Not given - bilateral renal artery stenosis | 25 | Not given - history of angio-oedema, hives, or rash in response to ACE inhibitors | 26 | Not given - hyperkalaemia | 27 | Not given - symptomatic hypotension | 28 | Not given - severe renal dysfunction | 29 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Aspirin therapy status | Number
[2]
| 10 | Given | 21 | Not given - patient refusal | 22 | Not given - true allergy to aspirin | 23 | Not given - active bleeding | 24 | Not given - bleeding risk | 29 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Beta-blocker therapy status | Number
[2]
| 10 | Given | 21 | Not given - patient refusal | 22 | Not given - allergy or history of intolerance | 23 | Not given - bradycardia (heart rate less than 50 beats per minute) | 24 | Not given - symptomatic acute heart failure | 25 | Not given - systolic blood pressure of less than 90 mmHg | 26 | Not given - PR interval greater than 0.24 seconds | 27 | Not given - second and third degree heart block or bifascicular heart block | 28 | Not given - asthma/airways hyper-reactivity | 29 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Bleeding episode using TIMI criteria (status) | Number
[1]
| 1 | Major | 2 | Minor | 3 | Non TIMI bleeding | 4 | None | 9 | Not stated/inadequately described |
| DSS specific information: Can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Blood pressure—diastolic (measured) | Number
[3]
| 999 | Not stated/inadequately described |
| |
- | Blood pressure—systolic (measured) | Number
[3]
| 999 | Not stated/inadequately described |
| |
- | Chest pain pattern category | Number
[1]
| 1 | Atypical chest pain | 2 | Stable chest pain pattern | 3 | Unstable chest pain pattern: rest &/or prolonged | 4 | Unstable chest pain pattern: new & severe | 5 | Unstable chest pain pattern: accelerated & severe | 8 | No chest pain/discomfort | 9 | Not stated/inadequately described |
| DSS specific information: The Canadian Cardiovascular Society classes of angina can be used to support categorisation of chest pain patterns. Canadian Cardiovascular Society (CCS) classes of angina (Campeau L. Grading of angina pectoris. Circulation 1976; 54:522.) - Ordinary physical activity (for example, walking or climbing stairs) does not cause angina; angina occurs with strenuous or rapid or prolonged exertion at work or recreation.
- Slight limitation of ordinary activity (for example, angina occurs walking or stair climbing after meals, in cold, in wind, under emotional stress, or only during the few hours after awakening; walking more than 2 blocks on the level or climbing more than 1 flight of ordinary stairs at a normal pace; and in normal conditions).
- Marked limitation of ordinary activity (for example, angina occurs with walking 1 or 2 blocks on the level or climbing 1 flight of stairs in normal conditions and at a normal pace).
- Inability to perform any physical activity without discomfort; angina syndrome may be present at rest.
|
- | Cholesterol—total (measured) | Number
[3]
| 99.9 | Not stated/inadequately described. |
| |
- | Clinical evidence of chronic lung disease (status) | Number
[1]
| 1 | Objective evidence | 2 | No objective evidence |
| DSS specific information: This data element seeks to ensure that patients with self-reported past symptoms pertinent to acute coronary syndrome, have objective evidence supporting reported diagnoses, using current medical practice. |
- | Clinical evidence of heart failure (status) | Number
[1]
| 1 | Objective evidence | 2 | No objective evidence |
| DSS specific information: This data element seeks to ensure that patients with self-reported past symptoms pertinent to acute coronary syndrome, have objective evidence supporting reported diagnoses, using current medical practice. |
- | Clinical evidence of peripheral arterial disease (status) | Number
[1]
| 1 | Objective evidence | 2 | No objective evidence |
| DSS specific information: This data element seeks to ensure that patients with self-reported past symptoms pertinent to acute coronary syndrome, have objective evidence supporting reported diagnoses, using current medical practice. |
- | Clinical evidence of sleep apnoea syndrome (status) | Number
[1]
| 1 | Objective evidence | 2 | No objective evidence |
| DSS specific information: This data element seeks to ensure that patients with self-reported past symptoms pertinent to acute coronary syndrome, have objective evidence supporting reported diagnoses, using current medical practice. |
- | Clinical evidence of stroke (status) | Number
[1]
| 1 | Objective evidence | 2 | No objective evidence |
| DSS specific information: This data element seeks to ensure that patients with self-reported past symptoms pertinent to acute coronary syndrome, have objective evidence supporting reported diagnoses, using current medical practice. |
- | Clinical procedure timing (status) | Number
[1]
| 1 | Procedure performed prior to an episode of admitted patient care | 2 | Procedure performed during an episode of admitted patient care |
| |
- | Clopidogrel therapy status | Number
[2]
| 10 | Given | 21 | Not given - therapy not indicated | 22 | Not given - patient refusal | 23 | Not given - true allergy to clopidogrel | 24 | Not given - active bleeding | 25 | Not given - bleeding risk | 26 | Not given - thrombocytopenia | 27 | Not given - severe hepatic dysfunction | 29 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Country of birth | Number
[4]
| NNNN A SACC code set representing a country. | |
- | Creatine kinase MB isoenzyme level (index code) | Number
[4]
| 9999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Creatine kinase MB isoenzyme level (percentage) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Creatine kinase MB isoenzyme level (kCat per litre) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Creatine kinase MB isoenzyme level (nanograms per decilitre) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Date creatine kinase MB isoenzyme measured | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Time creatine kinase MB isoenzyme measured | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | |
- | Creatine kinase MB isoenzyme level (international units) | Number
[4]
| 8888 | Not measured | 9999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Creatine kinase MB isoenzyme level (micrograms per litre) | Number
[4]
| 9999 | Not stated/inadequately described | 8888 | Not measured |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Creatinine serum level (measured) | String
[4]
| NN[NN] Number of micromoles per litre (µmol/L) | |
- | Date of birth | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Diabetes status | String
[2]
| 01 | Type 1 diabetes | 02 | Type 2 diabetes | 03 | Gestational diabetes mellitus (GDM) | 04 | Other (secondary diabetes) | 05 | Previous gestational diabetes mellitus (GDM) | 06 | Impaired fasting glucose (IFG) | 07 | Impaired glucose tolerance (IGT) | 08 | Not diagnosed with diabetes | 09 | Not assessed | 99 | Not stated/inadequately described |
| |
- | Electrocardiogram change location | Number
[1]
| 1 | Inferior leads: II, III, aVF | 2 | Anterior leads: V1 to V4 | 3 | Lateral leads: I, aVL, V5 to V6 | 4 | True posterior: V1 V2 | 8 | None | 9 | Not stated/inadequately described |
| |
- | Electrocardiogram change type | Number
[1]
| 1 | ST-segment elevation >= 1 mm (0.1 mV) in >= 2 contiguous limb leads | 2 | ST-segment elevation >= 2 mm (0.2 mV) in >= 2 contiguous chest leads | 3 | ST-segment depression >= 0.5 mm (0.05 mV) in >= 2 contiguous leads (includes reciprocal changes) | 4 | T-wave inversion >= 1 mm (0.1 mV) | 5 | Significant Q waves | 6 | Bundle branch block (BBB) | 7 | Non-specific | 8 | No changes | 9 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, used to determine diagnostic strata. |
- | Fibrinolytic drug used | Number
[1]
| 1 | Streptokinase | 2 | t-PA (Tissue Plasminogen Activator) (Alteplase) | 3 | r-PA (Reteplase) | 4 | TNK t-PA (Tenecteplase) | 9 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, this data element pertains to the administering of fibrinolytic therapy drugs at any time point during this current event. |
- | Fibrinolytic therapy status | Number
[2]
| 10 | Given | 21 | Not given - therapy not indicated | 22 | Not given - patient refusal | 23 | Not given - previous haemorrhagic stroke at any time; other strokes or cerebrovascular events within 1 year | 24 | Not given - known intracranial neoplasm | 25 | Not given - active or recent (within 2 to 4 weeks) internal bleeding (does not include menses) | 26 | Not given - suspected aortic dissection | 27 | Not given - severe uncontrolled hypertension on presentation (blood pressure >180 mmHg systolic and/or 110 mmHg diastolic). Note: This could be an absolute contraindication in low-risk patients with MI. | 28 | Not given - history of prior cerebrovascular accident or known intracerebral pathology not covered in 2.3 & 2.4 contraindications | 29 | Not given - current use of anticoagulants in therapeutic doses (INR greater than or equal to 2); known bleeding diathesis | 30 | Not given - recent trauma (within 2 to 4 weeks), including head trauma, traumatic or prolonged (greater than 10 minutes) CPR, or major surgery (less than 3 weeks) | 31 | Not given - pregnancy | 32 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, to be collected with the data elements Triage—triage date, DDMMYYYY, Triage—triage time, hhmm, Person—risk stratum, code N. This data element pertains to the administering of fibrinolytic therapy drugs at any time point during this current event. |
- | Date of first angioplasty balloon inflation or stenting | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: For Acute Coronary Syndrome (ACS) reporting, refers to the date of first angioplasty balloon inflation or coronary stenting for this admission. |
- | Time of first angioplasty balloon inflation or stenting | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | DSS specific information: For Acute coronary syndrome (ACS) reporting, refers to coronary arteries. |
- | Functional stress test element | Number
[1]
| 1 | ECG monitoring | 2 | Echocardiography | 3 | Radionuclide (perfusion) imaging (e.g. Thallium, Sestamibi) | 9 | Not stated/inadequately described |
| |
- | Functional stress test ischaemic result | Number
[1]
| 2 | Positive | 3 | Negative | 4 | Equivocal | 1 | Not done | 9 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be used to determine diagnostic strata. |
- | Glycoprotein IIb/IIIa receptor antagonist (status) | Number
[2]
| 10 | Given | 21 | Not given - therapy not indicated | 22 | Not given - patient refusal | 23 | Not given - known intracranial neoplasm | 24 | Not given - active or recent (within 2 to 4 weeks) internal bleeding (does not include menses). Suspected aortic dissection | 25 | Not given - history of prior cerebrovascular accident or known intracerebral pathology not covered in contraindications | 26 | Not given - recent trauma (within 2 to 4 weeks), including head trauma, traumatic or prolonged (greater than 10 minutes) CPR, or major surgery (less than 3 weeks) | 27 | Not given - pregnancy | 28 | Not given - other | 90 | Not stated/inadequately described |
| |
- | Heart rate | Number
[3]
| 997 | Cardiac arrest | 998 | Not recorded | 999 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, collected at time of presentation. If heart rate is not recorded at the exact time of presentation, record the first heart rate measured closest to the time of presentation. |
- | Heart rhythm type | String
[2]
| 1 | Sinus rhythm | 2 | Atrial fibrillation | 3 | Atrial flutter | 4 | Second degree heart block | 5 | Complete heart block | 6 | Supraventricular tachycardia | 7 | Idioventricular rhythm | 8 | Ventricular tachycardia | 9 | Ventricular fibrillation | 10 | Paced | 11 | Other rhythm | 99 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, the ECG used for assessment on presentation. |
- | Height (self-reported) | Number
[3]
| 888 | Unknown | 999 | Not stated/inadequately described |
| |
- | Cholesterol—HDL (measured) | Number
[3]
| 9.99 | Not measured/inadequately described |
| |
- | Indigenous status | Number
[1]
| 1 | Aboriginal but not Torres Strait Islander origin | 2 | Torres Strait Islander but not Aboriginal origin | 3 | Both Aboriginal and Torres Strait Islander origin | 4 | Neither Aboriginal nor Torres Strait Islander origin | 9 | Not stated/inadequately described |
| |
- | Date of intravenous fibrinolytic therapy | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | DSS specific information: For Acute coronary syndrome (ACS) reporting, refers to coronary arteries. |
- | Time of intravenous fibrinolytic therapy | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | DSS specific information: For Acute coronary syndrome (ACS) reporting, refers to coronary arteries. |
- | Killip classification code | Number
[1]
| 1 | Class 1 | 2 | Class 2 | 3 | Class 3 | 4 | Class 4 | 8 | Other | 9 | Not stated/inadequately described |
| DSS specific information: For Acute Coronary Syndrome (ACS) reporting, this data element describes the objective evidence of haemodynamic compromise by clinical examination at the time of presentation. Rales or crepitations represent evidence of pulmonary interstitial oedema on lung auscultation and an S3 is an audible extra heart sound by cardiac auscultation. |
- | Lipid-lowering therapy status | Number
[2]
| 10 | Given | 21 | Not given - patient refusal | 22 | Not given - true allergy to lipid lowering therapy | 23 | Not given - previous myopathy | 24 | Not given - hepatic dysfunction | 25 | Not given - other | 90 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, can be collected at any time point during the management of the current event (i.e. at the time of triage, at times during the admission, or at the time of discharge). |
- | Cholesterol—LDL (calculated) | Number
[3]
| 99.9 | Not stated/inadequately described |
| |
- | Myocardial infarction (history) | Number
[1]
| 1 | Myocardial infarction - occurred in the last 12 months | 2 | Myocardial infarction - occurred prior to the last 12 months | 3 | Myocardial infarction - occurred both in and prior to the last 12 months | 4 | No history of myocardial infarction | 9 | Not stated/inadequately described |
| DSS specific information: Myocardial infarction (MI) generally occurs as a result of a critical imbalance between coronary blood supply and myocardial demand. Decrease in coronary blood flow is usually due to a thrombotic occlusion of a coronary artery previously narrowed by atherosclerosis. MI is one of the most common diagnoses in hospitalised patients in industrialised countries. The most widely used in the detection of MI are creatinine kinase (CK) and (CK-MB), aspartate aminotransferase (AST) and lactate dehydrogenase (LD). Characteristic ECG changes include ST elevation, diminution of the R wave and a Q wave development. A recent study on Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI study) indicated that in diabetic patients with AMI, mortality is predicted by age, previous heart failure, and severity of the glycometabolic state at admission, but not by conventional risk factors or sex (American Heart Association 1999). |
- | Person identifier | String
[20]
| XXXXXX[X(14)]
A logical combination of valid alphanumeric characters that identify an entity. | |
- | Premature cardiovascular disease family history (status) | Number
[1]
| 1 | Yes | 2 | No | 3 | Family history status not known | 9 | Not recorded |
| |
- | Reason for readmission—acute coronary syndrome | Number
[2]
| 1 | ST elevation myocardial infarction | 2 | non-ST elevation ACS with high-risk features | 3 | non-ST elevation ACS with intermediate-risk features | 4 | non-ST elevation ACS with low-risk features | 5 | Planned Percutaneous Coronary Intervention (PCI) | 6 | Planned Coronary Artery Bypass Grafting (CABG) | 7 | Heart Failure (without MI) | 8 | Arrhythmia (without MI) | 9 | Conduction disturbance (without MI) | 88 | Non-cardiac cause | 99 | Not stated/inadequately described |
| |
- | Sex | Number
[1]
| 1 | Male | 2 | Female | 3 | Intersex or indeterminate | 9 | Not stated/inadequately described |
| |
- | Tobacco smoking status | Number
[1]
| 1 | Daily smoker | 2 | Weekly smoker | 3 | Irregular smoker | 4 | Ex-smoker | 5 | Never smoked |
| DSS specific information: Smoker type is used to define sub-populations of adults (age 18+ years) based on their smoking behaviour. Smoking has long been known as a health risk factor. Population studies indicate a relationship between smoking and increased mortality/morbidity. This metadata item can be used to estimate smoking prevalence.
Other uses are: - To evaluate health promotion and disease prevention programs (assessment of interventions)
- To monitor health risk factors and progress towards National Health Goals and Targets
|
- | Triglyceride level (measured) | Number
[3]
| 99.9 | Not stated/inadequately described. |
| |
- | Troponin assay type | Number
[1]
| 1 | Cardiac troponin T (cTnT) | 2 | Cardiac troponin I (cTnI) | 3 | Not taken | 9 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS) reporting, record the type of troponin assay (I or T) used to assess troponin levels during this presentation. |
- | Troponin level (measured) | Number
[4]
| 88.88 | Not measured | 99.99 | Not stated/inadequately described |
| DSS specific information: For Acute coronary syndrome (ACS ) reporting, can be used to determine diagnostic strata. |
- | Date troponin measured | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Time troponin measured | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | |
- | Vascular history | String
[2]
| 01 | Myocardial infarction | 02 | Unstable angina pectoris | 03 | Angina | 04 | Heart failure | 05 | Atrial fibrillation | 06 | Other dysrhythmia or conductive disorder | 07 | Rheumatic heart disease | 08 | Non-rheumatic valvular heart disease | 09 | Left ventricular hypertrophy | 10 | Stroke | 11 | Transient ischaemic attack | 12 | Hypertension | 13 | Peripheral vascular disease (includes abdominal aortic aneurism) | 14 | Deep vein thrombosis | 15 | Other atherosclerotic disease | 16 | Carotid stenosis | 17 | Vascular renal disease | 18 | Vascular retinopathy (hypertensive) | 19 | Vascular retinopathy (diabetic) | 97 | Other vascular | 98 | No vascular history | 99 | Unknown/not stated /not specified |
| |
- | Weight (self-reported) | Number
[3]
| | |
- | Date of triage | Date/Time
[8]
| DDMMYYYY
The day of a particular month and year. | |
- | Time of triage | Date/Time
[4]
| hhmm
A valid time measured as hours and minutes using a 24 hour clock. | |